Literature DB >> 17016036

Immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma.

Sándor Baráth1, Magdolna Aleksza, Katalin Keresztes, Judit Tóth, Sándor Sipka, Gyula Szegedi, Arpád Illés.   

Abstract

We aimed at investigating the distribution of various types of immunoregulatory T cells in the peripheral blood of patients with Hodgkin's lymphoma (HL) (n = 94) being in the state of long-lasting complete remission using flow cytometry. Healthy patients (n = 41) as 'negative' and patients in complete remission with breast cancer (n = 47) as 'positive' controls were investigated in the study. We found significant elevations in the number of CD4+ CD25high naturally occurring regulatory T cells, CD4+/intracellular IL-10+ (Tr1) and CD8+/intracellular IL-10+ T cells in HL compared to the healthy controls. In carcinoma patients, however, the number of Tr1 and CD8+/IL-10+ T cells was higher than that in the other two groups. The increase in the number of CD4+ CD25high T cells seems to be characteristic of HL compared to the two other types of regulatory T cells. This change exists for a long time and it seems to be a characteristic of HL and independent of the types of therapy and the duration of time since therapy. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016036     DOI: 10.1159/000094678

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  13 in total

1.  HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.

Authors:  Emilie Lanoy; Philip S Rosenberg; Fabien Fily; Anne-Sophie Lascaux; Valerie Martinez; Maria Partisani; Isabelle Poizot-Martin; Elisabeth Rouveix; Eric A Engels; Dominique Costagliola; James J Goedert
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

2.  Malignant lymphomas and autoimmunity-a single center experience from Hungary.

Authors:  László Váróczy; Edit Páyer; Zsuzsanna Kádár; Lajos Gergely; Zsófia Miltényi; Ferenc Magyari; Péter Szodoray; Arpád Illés
Journal:  Clin Rheumatol       Date:  2011-07-07       Impact factor: 2.980

3.  Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome.

Authors:  Larisa J Geskin; Oleg E Akilov; Soonyou Kwon; Michael Schowalter; Simon Watkins; Theresa L Whiteside; Lisa H Butterfield; Louis D Falo
Journal:  Cancer Immunol Immunother       Date:  2017-12-04       Impact factor: 6.968

Review 4.  Targeting Immune System Alterations in Hodgkin Lymphoma.

Authors:  Natalie S Grover; Barbara Savoldo
Journal:  Curr Hematol Malig Rep       Date:  2017-08       Impact factor: 3.952

Review 5.  Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.

Authors:  Xueyi Zheng; Yuhua Huang; Kai Li; Rongzhen Luo; Muyan Cai; Jingping Yun
Journal:  Viruses       Date:  2022-05-10       Impact factor: 5.818

6.  Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications.

Authors:  Mikhail Roshal; Brent L Wood; Jonathan R Fromm
Journal:  Adv Hematol       Date:  2010-11-28

7.  T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications.

Authors:  Claudio Fozza; Maurizio Longinotti
Journal:  Adv Hematol       Date:  2010-10-12

8.  Rare association of Hodgkin lymphoma, Graves' disease and myasthenia gravis complicated by post-radiation neurofibrosarcoma: coincidence or genetic susceptibility?

Authors:  Zsófia Simon; Zsuzsa Ress; József Toldi; Anita Trauninger; Zsófia Miltényi; Árpád Illés
Journal:  Int J Hematol       Date:  2009-04-21       Impact factor: 2.490

9.  Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells.

Authors:  Karl R N Baumforth; Anna Birgersdotter; Gary M Reynolds; Wenbin Wei; Georgia Kapatai; Joanne R Flavell; Emma Kalk; Karen Piper; Steve Lee; Lee Machado; Kerry Hadley; Anne Sundblad; Jan Sjoberg; Magnus Bjorkholm; Anna A Porwit; Lee-Fah Yap; Soohwang Teo; Richard G Grundy; Lawrence S Young; Ingemar Ernberg; Ciaran B J Woodman; Paul G Murray
Journal:  Am J Pathol       Date:  2008-05-23       Impact factor: 4.307

10.  Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma.

Authors:  Myoung Jae Kang; Kyoung Min Kim; Jun Sang Bae; Ho Sung Park; Ho Lee; Myoung Ja Chung; Woo Sung Moon; Dong Geun Lee; Kyu Yun Jang
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.